(Q44624222)

4 December 2017

0 references

Carbonic anhydrase-9 expression in head and neck cancer: a meta-analysis (English)

1 reference

4 December 2017

1 reference

1 reference

head and neck carcinoma

1 reference

Stamatios Peridis

1

1 reference

4 December 2017

Gemma Pilgrim

series ordinal

2

1 reference

4 December 2017

Ioannis Athanasopoulos

series ordinal

3

1 reference

4 December 2017

Konstantinos Parpounas

series ordinal

4

1 reference

4 December 2017

publication date

19 January 2011

1 reference

European Archives of Oto-Rhino-Laryngology

4 December 2017

published in

1 reference

4 December 2017

volume

268

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

661-670

1 reference

https://scigraph.springernature.com/pub.10.1007/s00405-011-1488-z

4 December 2017

exact match

0 references

cites work

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

Brachytherapy for oral tongue cancer: an analysis of treatment results with various biological markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

Assessment of microvessel density and carbonic anhydrase-9 (CA-9) expression in rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

Carbonic anhydrase IX as a marker for poor prognosis in soft tissue sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

Bringing it all together: Lancet-Cochrane collaborate on systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

Galectin-1: a link between tumor hypoxia and tumor immune privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

The prognostic value of hypoxia markers in T2-staged oral tongue cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: Prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1α-related markers, and hemoglobin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

Genome-wide expression analysis using microarray identified complex signaling pathways modulated by hypoxia in nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

Relation of Erythropoietin and Erythropoietin Receptor Expression to Hypoxia and Anemia in Head and Neck Squamous Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00405-011-1488-Z

Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours

21 January 2018

1 reference

12 December 2020

Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas

1 reference

12 December 2020

Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma

1 reference

12 December 2020

Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer

1 reference

12 December 2020

Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients

1 reference

12 December 2020

Hypoxia inducible factor (HIf1alpha and HIF2alpha) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy

1 reference

12 December 2020

Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix

1 reference

12 December 2020

Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma.

1 reference

12 December 2020

Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy

1 reference

12 December 2020

Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival

1 reference

12 December 2020

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

12 December 2020

Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma

1 reference

12 December 2020

Off-pump myocardial revascularization is associated with less incidence of stroke in elderly patients

1 reference

12 December 2020

The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON

1 reference

12 December 2020

Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density.

1 reference

12 December 2020

10.1007/S00405-011-1488-Z

Identifiers

DOI

1 reference

4 December 2017

1 reference